SEC Form 3 filed by new insider Gibney Anthony S
$IFRX
Biotechnology: Pharmaceutical Preparations
Health Care
| FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
| |||||||||||||||
1. Name and Address of Reporting Person*
(Street)
(Country) | 2. Date of Event Requiring Statement
(Month/Day/Year) 03/18/2026 | 3. Issuer Name and Ticker or Trading Symbol
InflaRx N.V. [ IFRX ] | |||||||||||||||
| 3a. Foreign Trading Symbol
| 5. If Amendment, Date of Original Filed
(Month/Day/Year) | ||||||||||||||||
| 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
| 6. Individual or Joint/Group Filing (Check Applicable Line)
| ||||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Ordinary Shares | 10,000 | D | |
| Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Stock Option (Right to Buy) | (1) | 02/07/2028 | Ordinary Shares | 11,667 | $1.86 | D | |
| Stock Option (Right to Buy) | (2) | 07/01/2031 | Ordinary Shares | 16,418 | $1.86 | D | |
| Stock Option (Right to Buy) | (3) | 01/11/2032 | Ordinary Shares | 30,000 | $1.86 | D | |
| Stock Option (Right to Buy) | (4) | 01/24/2033 | Ordinary Shares | 30,000 | $2.37 | D | |
| Stock Option (Right to Buy) | (5) | 01/05/2034 | Ordinary Shares | 30,000 | $1.79 | D | |
| Stock Option (Right to Buy) | (6) | 01/03/2035 | Ordinary Shares | 30,000 | $2.41 | D | |
| Stock Option (Right to Buy) | (7) | 01/06/2036 | Ordinary Shares | 30,000 | $1.17 | D | |
| Explanation of Responses: |
| 1. This option was granted on February 7, 2018 and is fully vested and exercisable as of the date hereof. |
| 2. This option was granted on July 2, 2021 and is fully vested and exercisable as of the date hereof. |
| 3. This option was granted on January 12, 2022 and is fully vested and exercisable as of the date hereof. |
| 4. This option was granted on January 24, 2023 and is fully vested and exercisable as of the date hereof. |
| 5. This option was granted on January 5, 2024 and is fully vested and exercisable as of the date hereof. |
| 6. This option was granted on January 3, 2025 and is fully vested and exercisable as of the date hereof. |
| 7. This option was granted on January 6, 2026 and will vest and become exercisable in four equal installments of 7,500 shares on each quarterly anniversary of such grant date, subject to continued service through such dates. |
| Remarks: |
| Exhibit List - Exhibit 24.1 Power of Attorney |
| /s/ Christian Schmid, Attorney-in-Fact | 03/18/2026 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
| * Form 3: SEC 1473 (03-26) | ||